Miller, Rust and Barbere Help Mileutis Obtain $20M Investment

October 20, 2020 | Corporate

Animal health company Mileutis Ltd., based in Israel, secured a $20 million investment from Raleigh, NC-based NovaQuest Capital Management LLC as part of a product financing agreement.

The investment will help Mileutis develop and commercialize Imilac, a product that will be used in the management, treatment and prevention of bovine mastitis, the most prevalent and costly disease in dairy herds worldwide.

This is NovaQuest’s first investment in the field of animal health care and in an Israeli company. Gregory Miller, Jeffrey Rust and Samantha Barbere represented Mileutis in negotiating the deal, together with Israeli counsel Lipa Meir & Co.

Share this article:

Related News

Get legal updates and news delivered to your inbox